Key result
Single intranasal dose of low-neuraminidase mutant influenza A protects mice against lethal wild-type challenge.
Why the study?
The effects of decreased neuraminidase levels on influenza A virus pathogenicity and potential for live attenuated vaccine development were unclear.
Answers are grounded in this paper and cite their sources.
Warrants evaluation as live-attenuated vaccine candidates; leaves open translation to human trials.
We have previously obtained four transfectant influenza A viruses containing neuraminidase (NA) genes with mutated base pairs in the conserved double-stranded RNA region of the viral promoter by using a ribonucleoprotein transfection system. Two mutant viruses (D2 and D1/2) which share a C-G-->A-U mutation at positions 11 and 12 of the 3' and 5' ends, respectively, of the NA gene, showed an approximate 10-fold reduction of NA-specific mRNA and protein levels (Fodor et al., Journal of Virology 72, 6283-6290, 1998). These viruses have now allowed us to determine the effects of decreased NA levels on virus pathogenicity. Both D2 and D1/2 viruses were highly attenuated in mice, and their replication in mouse lungs was highly compromised as compared with wild-type influenza A/WSN/33 virus. The results highlight the importance of the level of NA activity in the biological cycle and virulence of influenza viruses. Importantly, mice immunized by a single intranasal administration of 10(3) infectious units of D2 or D1/2 viruses were protected against challenge with a lethal dose of wild-type influenza virus. Attenuation of influenza viruses by mutations resulting in the decreased expression of a viral protein represents a novel strategy which could be considered for the generation of live attenuated influenza virus vaccines.
No takes yet. Share an insight, caveat, or question.
Solórzano et al. (2000) studied Influenza A virus infection. Mutant influenza A viruses (D2 and D1/2) with reduced neuraminidase levels vs. Wild-type influenza A/WSN/33 virus was evaluated on Virus pathogenicity, replication in mouse lungs, and protection against lethal challenge. Mutant influenza A viruses with reduced neuraminidase levels were highly attenuated in mice, and a single intranasal administration protected mice against a lethal dose of wild-type virus.
Synapse has enriched 10 related papers. Consider them for comparative context: